Oxidative stress induced by excessive
production of reactive oxygen
species (ROS) has been implicated in the etiology of many human diseases.
Acquiring a highly efficient antioxidant with good biocompatibility
is of significance in eliminating the deleterious effect induced by
the oxidative stress. Herein, we address our efforts on investigating
the cytoprotective effect of carboxyfullerenes on H<sub>2</sub>O<sub>2</sub>-injured cells. Meanwhile, the uptake and intracellular location
of carboxyfullerenes were studied. The results show that C<sub>70</sub>-carboxyfullerenes (dimalonic acid C<sub>70</sub> fullerene (DF<sub>70</sub>) and trimalonic acid C<sub>70</sub> fullerene (TF<sub>70</sub>)) exhibit an obviously protective effect against oxidative stress
on C2C12 cells at concentrations as low as 2.5 μmol L<sup>–1</sup>, whereas C<sub>60</sub>-carboxyfullerenes (dimalonic acid C<sub>60</sub> fullerene (DF<sub>60</sub>) and quadri-malonic acid C<sub>60</sub> fullerene (QF<sub>60</sub>)) show a protective effect at
relatively higher concentration (40 μmol L<sup>–1</sup>). The molecular structure of carboxyfullerenes and the physiological
state of cells play an important role in the different cytoprotective
capability. Further study reveals that DF<sub>70</sub> and TF<sub>70</sub> could enter into cells and mainly localize into the lysosome,
which possibly involves the protective mechanism by stabilizing lysosome.
The use of a significantly low concentration of C<sub>70</sub>-carboxyfullerene
as the antioxidative agent will benefit the therapeutic approaches
aiming at alleviating ROS-induced injuries such as muscle disorder
and arthritis.